Pharma major Sun Pharma posted a 5 percent year-on-year (YoY) rise in its consolidated net profit to ₹2,375.5 crore for the July-September quarter versus ₹2,262.22 crore in the same period last year. Meanwhile, its revenue rose over 11 percent YoY to ₹12,192 crore in the quarter under review as againstRead More →
Also Read: Large cap speciality chemical stock fixes record date for 350% dividend, LIC held 1.40% stake in Q4 It is worth noting that more than 5 Nifty majors will release their quarterly earnings this week. They are Bharat Petroleum Corporation, Hindalco Industries, Grasim Industries, Sun Pharmaceutical Industries, Oil andRead More →
MUMBAI : In a year rocked by volatility, foreign portfolio investors (FPIs) piled into FMCG stocks, boosting their prices and swelling their FMCG assets under custody by over ₹2 trillion. IT stocks remained least preferred with assets under custody falling to a little over ₹1.2 trillion during the same year,Read More →
Brokerage BNP Paribas thinks sector valuations look reasonable with FY25E EV/EBITDA averaging 12x for Pharma firms, 18x for Hospital firms and 21x for Diagnostics firms. Its detailed valuation workings for Diagnostics companies show that valuations are attractive now. “We believe the Indian Healthcare is on a long-term structural growth path.Read More →
